Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats

被引:25
|
作者
Ikeda, Y
Nakamura, T [1 ]
Takano, H
Kimura, H
Obata, JE
Takeda, S
Hata, A
Shido, K
Mochizuki, S
Yoshida, Y
机构
[1] Yamanashi Med Univ, Div Blood Transfus, Yamanashi 4093898, Japan
[2] Yamanashi Med Univ, Dept Internal Med, Yamanashi 4093898, Japan
[3] Yamanashi Med Univ, Dept Pathol, Yamanashi 4093898, Japan
[4] Hokkaido Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido 060, Japan
[5] Jikei Univ, Sch Med, Aoto Hosp, Dept Med, Tokyo, Japan
来源
关键词
D O I
10.1067/mlc.2000.105617
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Angiotensin-converting enzyme inhibitors (ACEIs) cause regression of hypertensive left ventricular hypertrophy (LVH) by reducing angiotensin II, increasing bradykinin, or both. The mechanisms of these cardioprotective effects remain controversial. The aims of this study were to determine whether the cardioprotective effects of ACEIs are mediated by reducing angiotensin II and whether ACEIs ameliorate the morphologic, physiologic, and biochemical changes in the hearts of stroke-prone spontaneously hypertensive rats (SHRSPs). Male SHRSPs were treated with hydralazine, captopril, or candesartan, an angiotensin II type 1 receptor(AT1R) antagonist, from age 12 to 24 weeks. We measured systolic blood pressure (SBP), left ventricular weight (LVW), left ventricular (LV) myocyte cross-sectional area (myocyte size), LV interstitial collagen volume fraction (ICVF), perivascular collagen area/luminal area ratio (PVCA/LA), the medial area to luminal area ratio (MA/LA), the relative amount of V3 myosin heavy chain (MHCV3), and coronary reserve maximum (coronary flow max/ventricular weight (CFmax/VW)). These parameters were compared with those of untreated SHRSPs and Wistar-Kyoto mts (WKYs). SHRSPs exhibited decreased coronary reserve and LVH with an increase in myocyte size, PVCA/LA, MA/LA, and MHCV3 at 12 weeks of age. In addition to these changes, 24-week-old SHRSPs showed an increase in ICVF. The LVW coronary reserve, myocyte size, PVCA/LA, ICVF, and MHCV3 of SHRSPs treated with captopril or candesartan all approached control values. In contrast, hydralazine decreased only ICVF. These results suggest that ACEIs regress LVH and normalize coronary reserve by modulating the effects of angiotensin II via AT1R on the induction of cardiomyocyte hypertrophy, perivascular fibrosis, and medial thickening of intramyocardial coronary arteries in SHRSPs. We concluded that these effects, in addition to the reduction of SEP, are important in causing the regression of LVH.
引用
收藏
页码:353 / 359
页数:7
相关论文
共 50 条
  • [21] Involvement of calcineurin in angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibroblast hyperplasia of rats
    Mingui Fu
    Song Xu
    Jifeng Zhang
    Yongzheng Pang
    Naikui Liu
    Jingyi Su
    Chaoshu Tang
    Heart and Vessels, 1999, 14 : 283 - 288
  • [22] Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats
    Naruse, M
    Tanabe, A
    Sato, A
    Takagi, S
    Tsuchiya, K
    Imaki, T
    Takano, K
    HYPERTENSION, 2002, 40 (01) : 28 - 33
  • [23] Involvement of calcineurin in angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibroblast hyperplasia of rats
    Fu, MG
    Xu, S
    Zhang, JF
    Pang, YZ
    Liu, NK
    Su, JY
    Tang, CS
    HEART AND VESSELS, 1999, 14 (06) : 283 - 288
  • [24] Aldosterone, but not angiotensin II, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats
    Chun, Tae-Yon
    Chander, Praveen N.
    Kim, Jong-Won
    Pratt, J. Howard
    Stier, Charles T., Jr.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 295 (02): : E305 - E312
  • [25] Nicotinamide Postpones Stroke in Stroke-Prone Spontaneously Hypertensive Rats
    Guo, Jin-Min
    Dong, Wen-Zhe
    Liu, Ai-Jun
    Cheng, Ming-He
    Su, Ding-Feng
    CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (03) : 267 - 268
  • [26] Gene related to stroke in stroke-prone spontaneously hypertensive rats
    Ikeda, K
    Yamori, Y
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (07) : 566 - 567
  • [27] STROKE PREVENTION BY LOSARTAN IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS
    STIER, CT
    ADLER, LA
    LEVINE, S
    CHANDER, PN
    JOURNAL OF HYPERTENSION, 1993, 11 : S37 - S42
  • [28] CEREBROVASCULAR LESIONS IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS
    FREDRIKSSON, K
    AUER, RN
    KALIMO, H
    NORDBORG, C
    OLSSON, Y
    JOHANSSON, BB
    ACTA NEUROPATHOLOGICA, 1985, 68 (04) : 284 - 294
  • [29] CEREBROVASCULAR PERMEABILITY IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS
    SHIBOTA, M
    SHINO, A
    NAGAOKA, A
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1978, 28 (03) : 330 - 337
  • [30] Reactive oxygen species (ROS) generation correlated with hypertensive cardiac fibrosis in stroke-prone spontaneously hypertensive rats (SHRSP)
    Shinzato, T.
    Ohya, Y.
    Akasaki, T.
    Sugama, I.
    Nakamoto, M.
    Takishita, S.
    JOURNAL OF HYPERTENSION, 2008, 26 : S275 - S275